Previous 10 | Next 10 |
PRA Health Sciences (PRAH) announces that Merck KGaA has selected the company's remote patient monitoring platform to work in combination with its human growth hormone ((HGH)) treatment system.Under this agreement, PRA’s remote patient monitoring platform will back Merck's HGH tre...
RALEIGH, N.C. , April 07, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) announced today that Merck KGaA, Darmstadt, Germany, known in the United States as EMD Serono, selected PRA’s remote patient monitoring platform to work in combination with its human growth hormone ...
ICON PLC is a Contract Research Organization that generated revenues of $2.8bn in FY20, and whose share price is +173% over a five-year period. Having potentially reached its rapid growth ceiling, the company has taken the decision to acquire its closest-matched sector rival PRA Healt...
Wells Fargo analyst Dan Leonard has upgraded shares of clinical research organization ICON plc (ICLR) from equal weight to overweight and is bumping up his price target to $235 from $200.Based on yesterday's closing price, that represents upside of ~20%.Leonard's bullishness is based on the c...
Gilead Sciences (GILD) is trading ~1.6% higher in the pre-market after Bernstein upgraded the stock to outperform from market perform.The analyst Aaron Gal expects that company to generate future catalysts and growth drivers the lack of which led the stock to remain undervalued in the pa...
RALEIGH, N.C., March 22, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) announced today the launch of its Patient-Centric Trial Development Toolkit, available now to clinical development sponsors focusing on rare diseases. Developed by PRA’s Center for Rare Diseases in c...
NEW YORK, NY / ACCESSWIRE / March 20, 2021 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: PRA Health Sciences, Inc. (NASDAQ:PRAH) concerning potential violations of the federal securities laws and/or breaches of fiduciary dutie...
Healthcare supply chain and pharma services companies weathered the COVID-19 volatility fairly well, and adapted to new realities along the way, Baird notes with the Q4 results in the rear-view mirror. The contract research organizations posted constant-dollar organic revenue growth of 10.2% ...
Glenview Capital Management’s 13F portfolio value increased from $3.19B to $4.36B this quarter. The number of positions increased from 45 to 54. They increased Lyft Inc. & Boston Scientific while reducing Meritor and Hologic during the quarter. The top three stakes are ...
Merger activity increased last week. Six multi-billion-dollar deals announced. SPAC frenzy hits a new record. For further details see: Merger Arbitrage Mondays: SPAC IPOs Set A New Record
News, Short Squeeze, Breakout and More Instantly...
PRA Health Sciences Inc. Company Name:
PRAH Stock Symbol:
NASDAQ Market:
PRA Health Sciences Inc. Website:
DT Midstream Set to Join S&P MidCap 400 DT Midstream Set to Join S&P MidCap 400 PR Newswire NEW YORK , June 28, 2021 /PRNewswire/ -- DT Midstream Inc. (NYSE: DTM) will replace PRA Health Sciences Inc. (NASD: PRAH) in the S&P MidCap 400 effective p...
Through this strategic partnership, the network aims to reach more than 25,000 physicians and 40 million patients, accelerating trial recruitment and enrollment efforts and expanding patients’ access to clinical research Veradigm®, a leading provider of healthcar...
Strengthening Board of Directors with Expertise in Innovative Product Launches NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiat...